Assuntos
Química Orgânica/métodos , Protease de HIV/síntese química , Sequência de Aminoácidos , Química Orgânica/instrumentação , Cromatografia Líquida de Alta Pressão , Protease de HIV/química , Protease de HIV/isolamento & purificação , HIV-1/enzimologia , Espectrometria de Massas , Dados de Sequência Molecular , Espectrometria de FluorescênciaRESUMO
Coccidioidomycosis is accepted as being noncontagious because the infectious arthroconidial form of Coccidioides immitis is not produced in humans and other mammalian hosts. However, disseminated coccidioidomycosis developed in a veterinarian who autopsied a horse with disseminated disease but without draining lesions or productive cough. We postulate transmission occurred by inhalation of tissue-phase endospores aerosolized in the course of dissection.
Assuntos
Autopsia/veterinária , Coccidioidomicose/transmissão , Doenças Profissionais/etiologia , Medicina Veterinária , Adulto , Anfotericina B/uso terapêutico , Animais , Coccidioides/isolamento & purificação , Coccidioidomicose/tratamento farmacológico , Coccidioidomicose/veterinária , Doenças dos Cavalos/transmissão , Cavalos , Humanos , Pneumopatias Fúngicas/tratamento farmacológico , Pneumopatias Fúngicas/etiologia , Masculino , Meningite Fúngica/tratamento farmacológico , Doenças Profissionais/tratamento farmacológico , Esporos FúngicosRESUMO
Since 1955, when amphotericin B was introduced into clinical therapy, a lore has grown up surrounding its use that often lacks evidential basis. Matters such as rate of intravenous injection, periodicity of administration, dosage, and the monitoring of therapy should not be shrouded in a mystique that is passed on from one generation of house officers to another. Factual rationalization of the use of amphotericin B should be pursued and is attempted in this article.
Assuntos
Anfotericina B/uso terapêutico , Micoses/tratamento farmacológico , Anfotericina B/administração & dosagem , Anfotericina B/efeitos adversos , Anfotericina B/química , Anemia/induzido quimicamente , Coração/efeitos dos fármacos , Humanos , Rim/efeitos dos fármacos , Estrutura Molecular , Sistema Nervoso/efeitos dos fármacosRESUMO
The location of biologically relevant epitopes on recombinant human beta interferon in which Ser-17 replaces Cys-17 (rh[Ser17]IFN-beta) was evaluated by testing the immunoreactivity of antibodies against 159 sequential, overlapping octamer peptides. Three monoclonal antibodies (mAbs) that neutralize rh[Ser17]IFN-beta biologic activity, designated A1, A5, and A7, bound to peptides spanning only residues 39-48, whereas nonneutralizing mAb bound less specifically at multiple sites near the amino terminus. The immunoreactivity of peptides spanning residues 40-47 that contained a series of single amino acid substitutions suggested that residues 41-43 (Pro-Glu-Glu) and 46 (Gln) are important for the binding of neutralizing mAbs. The reactivity of mAbs to larger synthetic peptides containing rh[Ser17]IFN-beta sequences from residue 32 through residue 56 was evaluated. All mAbs except A7 reacted with synthetic peptides representing rh[Ser17]IFN-beta residues 32-47, 40-56, and 32-56, but only mAbs A1 and A5 bound to the core peptide composed of residues 40-47. Peptide 32-56 effectively blocked the binding of mAbs A1 and A5 to rh[Ser17]IFN-beta and markedly inhibited their neutralizing activity. Biologic activity of the peptides was undetectable. Rabbit antisera raised against peptides 32-47 and 40-56 recognized rh[Ser17]IFN-beta but did not neutralize its antiviral activity. Thus, structure-function analysis by peptide mapping has permitted the identification of a linear epitope recognized by neutralizing antibody on a biologically active cytokine. We conclude that the region spanning residues 32-56 is of major importance in the expression of the biologic activity of human IFN-beta.
Assuntos
Interferon Tipo I/imunologia , Sequência de Aminoácidos , Animais , Anticorpos Monoclonais/imunologia , Epitopos , Técnicas In Vitro , Camundongos , Dados de Sequência Molecular , Mapeamento de Peptídeos , Peptídeos/imunologia , Conformação Proteica , Relação Estrutura-AtividadeRESUMO
Nineteen patients with phaeohyphomycosis were treated with itraconazole. Of these, 17 were assessable for clinical outcome. Of these, two had received no prior therapy, five had failed amphotericin B therapy, four had failed ketoconazole or miconazole therapy, and five had failed both amphotericin B and azole therapy. One patient had received only prior surgical intervention. Fungi of seven different genera caused disease of the skin in nine patients, soft tissue in nine, sinuses in eight, bone in five, joints in two, and lungs in two. Itraconazole was given in dosages ranging from 50 to 600 mg/day for 1 to 48 months. Clinical improvement or remission occurred in nine patients. Two patients have had stabilization of disease. Six patients failed treatment, one had a relapse after initially successful treatment. Itraconazole appears to be highly effective in some patients with phaeohyphomycosis, including patients refractory to other antifungal agents.
Assuntos
Antifúngicos/uso terapêutico , Cetoconazol/análogos & derivados , Micoses/tratamento farmacológico , Adulto , Idoso , Antifúngicos/efeitos adversos , Criança , Pré-Escolar , Esquema de Medicação , Feminino , Humanos , Itraconazol , Cetoconazol/efeitos adversos , Cetoconazol/uso terapêutico , Masculino , Testes de Sensibilidade Microbiana , Pessoa de Meia-Idade , Micoses/microbiologiaRESUMO
Human transforming growth factor alpha (TGF alpha) is a 50-residue mitogenic peptide with a compact structure restrained by three disulfide bonds. Sequential and overlapping synthetic peptides were made to identify epitopes of TGF alpha using a panel of murine monoclonal antibodies and rabbit polyclonal antibodies. Antibodies were raised against human TGF alpha from different preparations obtained from either chemical synthesis or recombinant DNA techniques. Two related methodologies were used in these experiments. In the first method, probes were synthesized as peptides immobilized on polyethylene pins by the method of Geysen et al. (Geysen, H. M., Meloen, R. H., and Barteling, S. J. (1984) Proc. Natl. Acad. Sci. U.S.A. 81, 3998-4002). Three sets of sequentially overlapping tetrapeptides, hexapeptides, and octapeptides covering the entire length of the human TGF alpha sequence were synthesized. In the second method, a set of overlapping 8-residue synthetic peptides, freely soluble in solution, were used as probes. By both methods, the nonneutralizing monoclonal antibodies, i.e. those that did not inhibit TGF alpha in mitogenic assays, recognized two immunodominant regions represented by the NH2-terminal segment (residues 1-9) and the most prominent beta-sheet of the molecule (residues 22-31). The NH2 terminus and the beta-sheet-(22-31) are in the same face of the molecule as determined by the solution structure. These two immunodominant regions were also recognized by the polyclonal antibodies as well as regions in the COOH terminus as minor epitopes. However, none of the neutralizing monoclonal antibodies recognized any synthetic peptides. Thus, our results suggest that the receptor-binding surface of TGF alpha does not involve the face represented by the NH2-terminal fragment and the major beta-sheet of residues 22-31, but rather, that the opposite face represented by two loops formed by residues 12-20 and 34-43 may be involved in TGF alpha binding to its receptor.
Assuntos
Fatores de Crescimento Transformadores , Sequência de Aminoácidos , Anticorpos , Anticorpos Monoclonais , Complexo Antígeno-Anticorpo , Ensaio de Imunoadsorção Enzimática , Epitopos/análise , Humanos , Cinética , Modelos Moleculares , Dados de Sequência Molecular , Conformação Proteica , Fatores de Crescimento Transformadores/imunologiaRESUMO
Amphotericin B methyl ester (AME) has been used to treat fungal infections, most often those caused by Coccidioides immitis. We describe the only patient with disseminated histoplasmosis who has been treated with AME. After having had alarming reactions to amphotericin B, the patient was treated and cured with AME without adverse drug effect or later relapse.
Assuntos
Anfotericina B/análogos & derivados , Antifúngicos/uso terapêutico , Histoplasmose/tratamento farmacológico , Idoso , Anfotericina B/efeitos adversos , Anfotericina B/uso terapêutico , Tolerância a Medicamentos , Humanos , MasculinoRESUMO
The therapeutic effect of recombinant human interleukin 2 (rH IL-2) was assessed in experimental murine coccidioidomycosis by daily IV injection for 30 days of doses ranging decimally from 2.5 X 10(1) to 2.5 X 10(5) units. The treatment with rH IL-2 had neither adverse nor salutary effects.
Assuntos
Coccidioidomicose/terapia , Interleucina-2/uso terapêutico , Anfotericina B/farmacologia , Animais , Feminino , Interleucina-2/farmacologia , Fígado/microbiologia , Pulmão/microbiologia , Camundongos , Proteínas Recombinantes/farmacologia , Proteínas Recombinantes/uso terapêutico , Baço/microbiologiaRESUMO
Multifocal systemic sporotrichosis (disseminated sporotrichosis) with lobar pulmonary involvement is uncommon. We describe successful treatment with amphotericin B in such a patient and review data from 1 other similar case previously reported and 7 with nonlobar pulmonary involvement.
Assuntos
Anfotericina B/uso terapêutico , Pneumopatias Fúngicas/tratamento farmacológico , Esporotricose/tratamento farmacológico , Idoso , Humanos , Pneumopatias Fúngicas/patologia , Masculino , Esporotricose/patologiaRESUMO
AME appeared to be as effective as AmB in the treatment of mycoses in humans. AME was much less nephrotoxic than AmB, and was better tolerated in terms of rapid onset and reversible adverse reactions. AME may be more ototoxic than AmB. AME, even as AmB and OAME, may cause neurotoxicity and leukoencephalopathy, particularly when high doses are given for long periods.
Assuntos
Anfotericina B/análogos & derivados , Antifúngicos/uso terapêutico , Micoses/tratamento farmacológico , Adulto , Idoso , Anfotericina B/uso terapêutico , Candidíase/tratamento farmacológico , Coccidioidomicose/tratamento farmacológico , Criptococose/tratamento farmacológico , Feminino , Seguimentos , Humanos , Masculino , Pessoa de Meia-IdadeRESUMO
The passage of antifungal agents into pulmonary parenchyma was studied in normal sheep prepared by cannulation of the right external jugular vein and the efferent duct of the right caudal mediastinal lymph node. Five sheep were given single, sequential, intravenous injections of flucytosine, ketoconazole, BAY n 7133, amphotericin B methyl ester, and amphotericin B. Venous blood plasma and pulmonary lymph were collected before infusion and from 5 min to 24 h postinfusion; the concentrations of the drugs were assayed by a well-agar diffusion method. All drugs appeared promptly in the pulmonary lymph and disappeared at approximately exponential rates from both liquids. The lymph/plasma ratios of the drug concentrations did not differ between flucytosine and the two azoles but were lower for both polyenes. Binding by plasma proteins did not appear to be a determinant of pulmonary entry.
Assuntos
Antifúngicos/metabolismo , Pulmão/metabolismo , Animais , Antifúngicos/sangue , Proteínas Sanguíneas/metabolismo , Feminino , Meia-Vida , Injeções Intravenosas , Cinética , Linfa/metabolismo , Ligação Proteica , OvinosRESUMO
Synthetic amino acid medium for fungi (SAAMF) is a totally defined, nutritionally adequate, macromolecule-free culture medium for fungi that is buffered with an organic weak acid-weak base pair: 2-(N-morpholino)-propanesulfonic acid (MOPS) and 2-amino-2-(hydroxymethyl)-1,3-propanediol (Tris). In 1984, it was reported that MOPS-Tris in SAAMF antagonized the activity of flucytosine against Candida albicans (D. L. Calhoun and J. N. Galgiani, Antimicrob. Agents Chemother. 26:364-367, 1984). Accordingly, we evaluated the buffering capacity of seven synthetic organic buffers and monobasic potassium phosphate, both singly and in pairs, over the pH range 7.4 to 6.0. Of these buffers, MOPS, BES [N,N-bis(2-hydroxyethyl)-2-aminomethanesulfonic acid], a BES-MOPS combination, and KH2PO4 provided the best buffering. Growth of C. albicans, in unbuffered SAAMF was equivalent overall to that in SAAMF containing buffers, singly or in pairs. Twelve strains of C. albicans and five strains of Candida lusitaniae were tested for susceptibility to flucytosine in SAAMF, with and without buffers. In the presence of Tris, the geometric mean MICs were 6.5- and 3.6-fold higher, respectively, for C. albicans and C. lusitaniae. We recommend replacing Tris with the nonantagonistic MOPS.
Assuntos
Candida albicans/efeitos dos fármacos , Candida/efeitos dos fármacos , Flucitosina/farmacologia , Soluções Tampão , Candida/crescimento & desenvolvimento , Candida albicans/crescimento & desenvolvimento , Meios de Cultura , Humanos , Concentração de Íons de Hidrogênio , Testes de Sensibilidade MicrobianaRESUMO
Cohorts of ten mice, uninfected and infected (intratracheal injection of coccidioidal arthroconidia), were treated for 23 days by intravenous injections of either 5% glucose solution, an immunostimulant (forphenicinol), an immunodepressant (cyclosporine), or amphotericin B. All mice were autopsied (survivors at 26 days postinoculation) and suspensions of lungs, livers, and spleens were cultured. All uninfected animals survived and gained weight, whereas, only 20% of the infected controls survived, and all lost weight. Treatment with forphenicinol had no effect on survival or weight. Cyclosporine secured 90% survival at the lowest dose and 60% at the higher doses, with no net loss of weight; however, all cultures of organs yielded heavy growth of Coccidioides immitis. With amphotericin B, all mice survived and gained weight; four mice from each of the two treatment groups yielded modest growth of C. immitis from the lungs, and one mouse of each group yielded sparse growth from liver and spleen. The paradox of no effect from an immunostimulant and therapeutic effect from an immunodepressant correlated with susceptibility testing of C. immitis in vitro.
Assuntos
Anfotericina B/uso terapêutico , Antibacterianos/uso terapêutico , Coccidioidomicose/tratamento farmacológico , Ciclosporinas/uso terapêutico , Glicina/análogos & derivados , Anfotericina B/farmacologia , Animais , Antibacterianos/farmacologia , Peso Corporal , Coccidioides/efeitos dos fármacos , Coccidioides/isolamento & purificação , Ciclosporinas/farmacologia , Feminino , Glicina/farmacologia , Glicina/uso terapêutico , Fígado/microbiologia , Pulmão/microbiologia , Camundongos , Baço/microbiologiaRESUMO
Following cannulation of the right external jugular vein and the efferent duct of the right caudal mediastinal lymph node (the caudal end of this node was ligated to cut off the inflow of systemic lymph, i.e., 90%-95% of the efferent lymph was of pulmonary origin), sheep were given either tetracycline or minocycline as single doses of 5 mg/kg body weight infused intravenously over 30 min. Venous blood plasma and pulmonary lymph collected contemporaneously before infusion and from 5 min to 24 hr postinfusion were assayed by a well-agar diffusion method using Bacillus cereus. Peak concentrations of both drugs were observed in both plasma and lymph at 5 min postinfusion. Tetracycline penetrated into the lymph better than minocycline (percent penetration 67.3% of cf. 38.2%). The concentration of tetracycline was significantly higher in lymph during and 5 min postinfusion (p less than 0.01), a factor that may be of importance when selecting a tetracycline for the treatment of a pulmonary infection.
Assuntos
Pulmão/metabolismo , Linfa/metabolismo , Minociclina/metabolismo , Tetraciclina/metabolismo , Tetraciclinas/metabolismo , Animais , Cinética , Minociclina/sangue , Ligação Proteica , Ovinos , Tetraciclina/sangue , Distribuição TecidualRESUMO
Two adult patients with pericarditis caused by beta-lactamase producing Haemophilus influenzae are reported and their management reviewed. Both had pharyngitis, epiglottitis, pneumonia, empyema, or septicemia and were cured with antimicrobics and pericardial drainage (one by catheter and one by surgery). Eleven previously reported cases of pericarditis caused by Haemophilus influenzae are also reviewed. In reviewing this rare cause of bacteria pericarditis, it is important to recognize the antibiotic resistance profile, the incidence of pericardial tamponade, and the use of surgical drainage. Antibiotic selection for this organism is also discussed, as well as the importance of biotyping.
RESUMO
A region of human interleukin-2 (IL-2) which was predicted to be a contact point with its receptor was used to locate a homologous region in the envelope protein of human T-lymphotropic retrovirus (HTLV-III). This homologous six amino acid peptide from the carboxy (C)-terminus of the HTLV-III envelope protein was found to inhibit the biological activity of human IL-2 in a murine spleen cell proliferation assay. When conjugated to a carrier protein, this peptide inhibited the binding of radiolabelled IL-2 to its receptor. The biological activity of the peptide was antagonized by a six amino acid peptide fragment of the IL-2 receptor which was predicted to be the contact point on the receptor that corresponded to the binding region of IL-2. The HTLV-III peptide also inhibited the binding of radiolabelled IL-2 to polyclonal anti-IL-2 antiserum. These data support the previous assignment of contact points between IL-2 and its receptor. They also suggest two possible mechanisms of immunosuppression during acquired immunodeficiency syndrome (AIDS). One involves direct competition of the envelope protein or its fragments with IL-2 for binding to the IL-2 receptor. The other involves antibodies to the envelope protein which crossreact with and neutralize IL-2.
Assuntos
HIV/análise , Interleucina-2/análise , Oligopeptídeos/análise , Receptores Imunológicos/metabolismo , Proteínas do Envelope Viral/análise , Sequência de Aminoácidos , Sítios de Ligação , HIV/patogenicidade , Tolerância Imunológica , Interleucina-2/imunologia , Interleucina-2/metabolismo , Receptores de Interleucina-2RESUMO
The effect of four culture media (two complex and undefined [Sabouraud glucose and Kimmig] and two synthetic and defined [synthetic amino acid medium, fungal, and modified yeast nitrogen base]) on the activity in vitro of two newer azole compounds (BAY n 7133 and ketoconazole) was assessed with five strains each of Candida albicans, Candida parapsilosis, and Cryptococcus neoformans. Also, the nutritional adequacy of the four media was evaluated with the same 15 strains of yeastlike fungi. While the MICs of BAY n 7133 were higher in the complex media, the activity of ketoconazole was little affected. The Candida spp. grew least well and the C. neoformans grew best in yeast nitrogen base.